Kurkinorin
Appearance
| Clinical data | |
|---|---|
| Drug class | μ-Opioid receptor agonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C28H28O8 |
| Molar mass | 492.524 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Kurkinorin is a non-nitrogenous, extremely selective centrally acting μ-opioid receptor agonist derived from salvinorin A[1] with no sedating or rewarding effects.[2]
See also
[edit]References
[edit]- ↑ Crowley RS, Riley AP, Alder AF, Anderson RJ, Luo D, Kaska S, Maynez P, Kivell BM, Prisinzano TE (June 2020). "Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein Activation Bias at the μ-Opioid Receptor". ACS Chemical Neuroscience. 11 (12): 1781–1790. doi:10.1021/acschemneuro.0c00191. PMC 7359744. PMID 32383854.
- ↑ Shivaperumal, Nirajmohan (May 18, 2017). Investigating the analgesic properties of Kurkinorin, a novel mu-opioid receptor analogue of Salvinorin A (Masters). Victoria University of Wellington.